These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 19558005)
1. The Urticaria Severity Score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticaria. Jariwala SP; Moday H; de Asis ML; Fodeman J; Hudes G; de Vos G; Rosenstreich D Ann Allergy Asthma Immunol; 2009 Jun; 102(6):475-82. PubMed ID: 19558005 [TBL] [Abstract][Full Text] [Related]
2. Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life. Lennox RD; Leahy MJ Ann Allergy Asthma Immunol; 2004 Aug; 93(2):142-6. PubMed ID: 15328673 [TBL] [Abstract][Full Text] [Related]
3. Use of the Dermatology Life Quality Index (DLQI) in a midwestern US urban clinic. Hahn HB; Melfi CA; Chuang TY; Lewis CW; Gonin R; Hanna MP; Farmer ER J Am Acad Dermatol; 2001 Jul; 45(1):44-8. PubMed ID: 11423833 [TBL] [Abstract][Full Text] [Related]
4. Cross-cultural adaptation of the Brazilian-Portuguese version of the chronic urticaria quality-of-life questionnaire - CU-Q2oL. Dias GA; Pires GV; Valle SO; França AT; Papi JA; Dortas SD; Levy SA; Baiardini I; Canonica GW Allergy; 2011 Nov; 66(11):1487-93. PubMed ID: 21899558 [TBL] [Abstract][Full Text] [Related]
5. Minimal important difference (MID) of the Dermatology Life Quality Index (DLQI): results from patients with chronic idiopathic urticaria. Shikiar R; Harding G; Leahy M; Lennox RD Health Qual Life Outcomes; 2005 May; 3():36. PubMed ID: 15907211 [TBL] [Abstract][Full Text] [Related]
6. Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validity. Kocatürk E; Weller K; Martus P; Aktas S; Kavala M; Sarigul S; Baiardini I; Canonica GW; Brzoza Z; Kalogeromitros D; Maurer M Acta Derm Venereol; 2012 Jul; 92(4):419-25. PubMed ID: 21918791 [TBL] [Abstract][Full Text] [Related]
7. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease. Basra MK; Sue-Ho R; Finlay AY Br J Dermatol; 2007 Mar; 156(3):528-38. PubMed ID: 17300244 [TBL] [Abstract][Full Text] [Related]
8. Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire. Ertaş M; Siva A; Dalkara T; Uzuner N; Dora B; Inan L; Idiman F; Sarica Y; Selçuki D; Sirin H; Oğuzhanoğlu A; Irkeç C; Ozmenoğlu M; Ozbenli T; Oztürk M; Saip S; Neyal M; Zarifoğlu M; Headache; 2004 Sep; 44(8):786-93. PubMed ID: 15330825 [TBL] [Abstract][Full Text] [Related]
9. Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial. Feldman SR; Gordon KB; Bala M; Evans R; Li S; Dooley LT; Guzzo C; Patel K; Menter A; Gottlieb AB Br J Dermatol; 2005 May; 152(5):954-60. PubMed ID: 15888152 [TBL] [Abstract][Full Text] [Related]
10. Validity and reliability of the Modified Manchester Health Questionnaire in assessing patients with fecal incontinence. Kwon S; Visco AG; Fitzgerald MP; Ye W; Whitehead WE; Dis Colon Rectum; 2005 Feb; 48(2):323-31; discussion 331-4. PubMed ID: 15616750 [TBL] [Abstract][Full Text] [Related]
11. Life quality of Chinese patients with chronic urticaria as assessed by the dermatology life quality index. Liu JB; Yao MZ; Si AL; Xiong LK; Zhou H J Eur Acad Dermatol Venereol; 2012 Oct; 26(10):1252-7. PubMed ID: 21958389 [TBL] [Abstract][Full Text] [Related]
12. The Pictorial Representation of Illness and Self Measure (PRISM) instrument reveals a high burden of suffering in patients with chronic urticaria. Töndury B; Muehleisen B; Ballmer-Weber BK; Hofbauer G; Schmid-Grendelmeier P; French L; Büchi S J Investig Allergol Clin Immunol; 2011; 21(2):93-100. PubMed ID: 21462798 [TBL] [Abstract][Full Text] [Related]
13. The Neck Bournemouth Questionnaire cross-cultural adaptation into Dutch and evaluation of its psychometric properties in a population with subacute and chronic whiplash associated disorders. Schmitt MA; de Wijer A; van Genderen FR; van der Graaf Y; Helders PJ; van Meeteren NL Spine (Phila Pa 1976); 2009 Nov; 34(23):2551-61. PubMed ID: 19927105 [TBL] [Abstract][Full Text] [Related]
14. Effect on quality of life in patients with pityriasis rosea: is it associated with rash severity? Chuh AA; Chan HH Int J Dermatol; 2005 May; 44(5):372-7. PubMed ID: 15869534 [TBL] [Abstract][Full Text] [Related]
15. The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings. Młynek A; Magerl M; Hanna M; Lhachimi S; Baiardini I; Canonica GW; Brzoza Z; Kasperska-Zajac A; Rogala B; Zalewska-Janowska A; Zuberbier T; Maurer M Allergy; 2009 Jun; 64(6):927-36. PubMed ID: 19453340 [TBL] [Abstract][Full Text] [Related]
16. The development of a questionnaire to measure the severity of symptoms and the quality of life before and after surgery for stress incontinence. Kulseng-Hanssen S; Borstad E BJOG; 2003 Nov; 110(11):983-8. PubMed ID: 14592582 [TBL] [Abstract][Full Text] [Related]
17. Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome. García-Borreguero D; Kohnen R; Högl B; Ferini-Strambi L; Hadjigeorgiou GM; Hornyak M; de Weerd AW; Happe S; Stiasny-Kolster K; Gschliesser V; Egatz R; Cabrero B; Frauscher B; Trenkwalder C; Hening WA; Allen RP Sleep Med; 2007 Aug; 8(5):455-63. PubMed ID: 17543579 [TBL] [Abstract][Full Text] [Related]
18. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Baiardini I; Pasquali M; Braido F; Fumagalli F; Guerra L; Compalati E; Braga M; Lombardi C; Fassio O; Canonica GW Allergy; 2005 Aug; 60(8):1073-8. PubMed ID: 15969690 [TBL] [Abstract][Full Text] [Related]
19. DLQI scores in vitiligo: reliability and validity of the Persian version. Aghaei S; Sodaifi M; Jafari P; Mazharinia N; Finlay AY BMC Dermatol; 2004 Aug; 4():8. PubMed ID: 15294022 [TBL] [Abstract][Full Text] [Related]
20. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change. Lindsay RM; Heidenheim PA; Nesrallah G; Garg AX; Suri R; Clin J Am Soc Nephrol; 2006 Sep; 1(5):952-9. PubMed ID: 17699312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]